Combining ear nerve stimulation and brain magnetic stimulation for depression treatment
Official title: Synchronized Cervical or Auricular VNS With Prefrontal rTMS for Treatment Resistant Depression (TRD)
Run by Medical University of South Carolina · NCT05725239 · Data updated 2026-11-12
This study is testing if combining ear nerve stimulation with brain magnetic stimulation can help people with depression who haven’t found relief from regular medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | March 14, 2023 |
| Main results expected | June 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT05725239 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 who are experiencing depression and have either undergone cervical VNS or have tried and failed two antidepressant medications.
✕Probably not a fit
Patients with preexisting neurological disorders, significant cognitive impairments, or current suicidal intent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to evaluate a combined treatment approach for depression by using transcutaneous auricular vagus nerve stimulation (taVNS) alongside transcranial magnetic stimulation (TMS). Participants will undergo a screening session followed by six treatment days, where they will receive either taVNS, TMS, or both in a randomized order. The study is conducted in-person at the Institute of Psychiatry in Charleston, South Carolina, and targets individuals who have not responded to traditional antidepressant medications. The goal is to determine if this combined method can more effectively alleviate depressive symptoms compared to each treatment alone.
Why it matters
Potential benefit: If successful, this combined treatment could provide a more effective option for patients suffering from depression who have not responded to standard therapies.
How similar studies have gone: While the combination of taVNS and TMS is a novel approach, similar studies exploring each treatment individually have shown promise in alleviating depressive symptoms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-75 years old * Undergoing cervical VNS or have tried and failed two antidepressant medications in the current episode * Able to provide informed consent * English speaking and can read and write * 17-item Hamilton Depression Rating Scale (HAM-D) score ≥20 * Not responding to talking therapy. Exclusion Criteria: * Preexisting neurological disorders, or dementia * History of major head trauma * Life expectancy \<1 year * Any type of cognitive impairment that would require approval/signature of a legal guardian/representative for participation * A score of \>2 on question 3 of the Hamilton Depression Rating pertaining to suicidality * Current active suicidal intent or plan, prior attempt within the last 6 months, or who in the judgment of the investigator would be at elevated risk for suicide will be excluded * Patients who are pregnant will also be excluded. We will require a pregnancy test for individuals of child-bearing potential.
Where it's running
-
Medical University of South Carolina Institute of Psychiatry
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Mark George, MD — Medical University of South Carolina
- Study coordinator: Mark George
- Email: georgem@musc.edu
- Phone: 843-876-5142
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.